NEW YORK, Jan. 6 (GenomeWeb News) - BioMerieux of Marcy-l'Etoile, France, plans to develop molecular diagnostics systems using Cepheid's platform technologies, Sunnyvale, Calif.-based Cepheid said today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.